Quarterly report · Q2
6894.TEDINET S100PJH5
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥94m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥116m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥120m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥352m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥131m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥119m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥131m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥82m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥340m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥113m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥82m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥113m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥4.4bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥4.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥4.1bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.4bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥191m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥659m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥295m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥19m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥66m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥37m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥130m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥72m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥66m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥60.11 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.99 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥248.75 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.61 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.9% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥556m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥556m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥48m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥335m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥335m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥288m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥288m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥84m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥234m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥530m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥530m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥100m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥321m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥321m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥84m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥257m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥257m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥78m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥262m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 420
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes paid ope cf | Prior1YTDDuration | -338000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -78770000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 294740000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -190813000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -36904000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -19292000 | JPY |
| Other net inv cf | Prior1YTDDuration | 101000 | JPY |
| Other net inv cf | CurrentYTDDuration | -29000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -36803000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -19322000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -5160000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -15968000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -73000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -76000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -61199000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -114216000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -66433000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -130260000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 3251000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 12668000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 194755000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -327727000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1675979000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 2212632000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1870735000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1884904000 | JPY |
| Payroll and allowances sga | Prior1YTDDuration | 97535000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration | 100301000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 19882000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 21813000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 6686000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 6230000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 256838000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | 530062000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 321449000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1108350000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 256838000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | 530062000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 321449000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1108350000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 78257000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | 100401000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 83821000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 262480000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 287754000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | 556255000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |